These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33731554)

  • 41. Considerations for the design of overdose education and naloxone distribution interventions: results of a multi-stakeholder workshop.
    Sellen K; Markowitz B; Parsons JA; Leece P; Handford C; Goso N; Hopkins S; Klaiman M; Shahin R; Milos G; Wright A; Charles M; Morrison L; Strike C; Orkin A;
    BMC Public Health; 2023 May; 23(1):888. PubMed ID: 37189052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Naloxone administration among opioid-involved overdose deaths in 38 United States jurisdictions in the State Unintentional Drug Overdose Reporting System, 2019.
    Quinn K; Kumar S; Hunter CT; O'Donnell J; Davis NL
    Drug Alcohol Depend; 2022 Jun; 235():109467. PubMed ID: 35461083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stigma by Association: To what Extent is the Attitude Toward Naloxone Affected by the Stigma of Opioid Use Disorder?
    Adeosun SO
    J Pharm Pract; 2023 Aug; 36(4):941-952. PubMed ID: 35505618
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Take-home Naloxone at Opioid Treatment Programs: A Lifesaver.
    Katzman JG; Bhatt S; Comerci GD
    J Addict Med; 2022 Nov-Dec 01; 16(6):619-621. PubMed ID: 35220332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protocol for a mixed-methods feasibility study for the surviving opioid overdose with naloxone education and resuscitation (SOONER) randomised control trial.
    Orkin A; Campbell D; Handford C; Hopkins S; Klaiman M; Leece P; Parsons JA; Shahin R; Strike C; Thorpe K; Sellen K; Milos G; Wright A; Charles M; Sniderman R; Morrison L;
    BMJ Open; 2019 Nov; 9(11):e029436. PubMed ID: 31722937
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opioid education and nasal naloxone rescue kits in the emergency department.
    Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
    West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations.
    Ellis MS; Kasper ZA; Gold M; Cicero TJ
    J Addict Med; 2023 Mar-Apr 01; 17(2):197-205. PubMed ID: 36148998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of a pharmacist-led naloxone education and community distribution project on local use of naloxone.
    Wright QE; Higginbotham S; Bunk E; Covvey JR
    J Am Pharm Assoc (2003); 2020; 60(3S):S56-S60. PubMed ID: 31953118
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Addiction stigma and the production of impediments to take-home naloxone uptake.
    Fomiatti R; Farrugia A; Fraser S; Dwyer R; Neale J; Strang J
    Health (London); 2022 Mar; 26(2):139-161. PubMed ID: 32529843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Attitude changes following short-form opioid overdose video education: a pilot study.
    Galiher MV; Huffman M
    Harm Reduct J; 2022 Oct; 19(1):114. PubMed ID: 36241995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Community Case Study of Naloxone Distribution by Hospital-Based Harm Reduction Program for People Who Use Drugs in New York City.
    Riazi F; Toribio W; Irani E; Hughes TM; Huxley-Reicher Z; McBratney E; Vu T; Sigel K; Weiss JJ
    Front Sociol; 2021; 6():619683. PubMed ID: 34307540
    [No Abstract]   [Full Text] [Related]  

  • 52. Community-based opioid overdose prevention programs providing naloxone - United States, 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(6):101-5. PubMed ID: 22337174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Community-Based Response to Fentanyl Overdose Outbreak, San Francisco, 2015.
    Rowe C; Wheeler E; Stephen Jones T; Yeh C; Coffin PO
    J Urban Health; 2019 Feb; 96(1):6-11. PubMed ID: 29725887
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Military veterans' overdose risk behavior: Demographic and biopsychosocial influences.
    Bennett AS; Watford JA; Elliott L; Wolfson-Stofko B; Guarino H
    Addict Behav; 2019 Dec; 99():106036. PubMed ID: 31494452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Massachusetts Department of Public Health Post Overdose Support Team Initiative: A Public Health-Centered Co-Response Model for Post-Overdose Outreach.
    Formica SW; Reilly B; Duska M; Ruiz SC; Lagasse P; Wheeler M; Delaney A; Walley AY
    J Public Health Manag Pract; 2022 Nov-Dec 01; 28(Suppl 6):S311-S319. PubMed ID: 36194799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimizing naloxone distribution to prevent opioid overdose fatalities: results from piloting the Systems Analysis and Improvement Approach within syringe service programs.
    Patel SV; Wenger LD; Kral AH; Sherr K; Wagner AD; Davidson PJ; Lambdin BH
    BMC Health Serv Res; 2023 Mar; 23(1):278. PubMed ID: 36949494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The changing epidemiology of opioid overdose in Baltimore, Maryland, 2012-2017: insights from emergency medical services.
    Dun C; Allen ST; Latkin C; Knowlton A; Weir BW
    Ann Med; 2022 Dec; 54(1):1738-1748. PubMed ID: 35775468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic.
    Dadiomov D; Bolshakova M; Mikhaeilyan M; Trotzky-Sirr R
    Harm Reduct J; 2022 Jun; 19(1):69. PubMed ID: 35768817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Healthcare costs and use before and after opioid overdose in Veterans Health Administration patients with opioid use disorder.
    Joyce VR; Oliva EM; Garcia CC; Trafton J; Asch SM; Wagner TH; Humphreys K; Owens DK; Bounthavong M
    Addiction; 2023 Nov; 118(11):2203-2214. PubMed ID: 37465971
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of a personally-tailored opioid overdose prevention education and naloxone distribution intervention to promote harm reduction and treatment readiness in individuals actively using illicit opioids.
    Winhusen T; Wilder C; Lyons MS; Theobald J; Kropp F; Lewis D
    Drug Alcohol Depend; 2020 Nov; 216():108265. PubMed ID: 32919098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.